Going for Broke

Biotechs are running out of cash, reports the Wall Street Journal. (OK, you probably already knew that.) In the past four months, 10 biotechs have gone bankrupt and, currently, 120 of the 360 publicly traded companies have less than six months' worth of cash -- the Journal's Health blog speculates that no one will be able to support the small biotechs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.